Company: MBVI
Filing Date: 2025-08-18
Form Type: S-1/A
Source: 0001213900-25-078000
Chunk: 10

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-08-18
Form: S-1/A
Chunk 10
---
 additional 1,500,000 private placement warrants, which private placement warrants may result in material dilution to our public shareholders if exercised on a cashless basis. See “ Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline”, “ — We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the Class B ordinary shares at a ratio greater than one -to-one in connection with our initial business combination as a result of the anti -dilution provisions contained in our amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely present other risks”, “— The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary shares at such time is substantially less than $10.00 per share”and “Dilution.”

The following table illustrates the difference between the public offering price per unit and our net tangible book value per share (“NTBV”), as adjusted to give effect to this offering and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over -allotmentoption. See “ Dilution.”

| As of June 10, 2025 |                                                 |     |                |      |     |            |      |     |                |      |     |            |      |     |                |      |     |            |      |     |            |       |   |     |            |       |
|:--------------------|------------------------------------------------:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:-----------|:------|:--|:----|:-----------|------:|
| Offering            
 Price of            
 $10.